Novavax shareholder Shah Capital to step back from activist role

By Reuters News

Oct 16 (Reuters) - Shah Capital, one of Novavax's NVAX.O top shareholders, said on Friday it no longer seeks to influence control of the vaccine maker after restructuring into a family office.

  • The investor has filed with the US Securities and Exchange Commission to voluntarily withdraw its registration as an investment adviser, it said in a regulatory filing

  • Himanshu Shah Family Office LLC has been established to manage the investments, the filing said‌

  • Himanshu Shah is the founder, president and chief investment officer of Shah Capital, Novavax's second-largest shareholder, according to LSEG data

  • Shah Capital reported beneficial ownership of 10.54 million Novavax shares, or about 6.39% of the company

  • The filing also disclosed that Shah Capital Fund LLC sold 2.87 million shares on October 5 at an average price of about $11.35 apiece

  • Himanshu Shah reported beneficial ownership of 10.66 million shares, representing about 6.46% of Novavax

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.